CAS RN: 54328-33-5

Dermatan Sulfate Sodium Salt

Product Availability

Choose a grade to view its available package options.

8 package records5 with current stock4 grade groups
Batch No.PackageAvailabilityInquiry
Batchno.20260421 100mg In stock Inquiry
Batchno.20250101 25mg In stock Inquiry
Batch No.PackageAvailabilityInquiry
Batchno.20260506 1mg Out of stock Inquiry
Batchno.20250828 5mg In stock Inquiry
Batch No.PackageAvailabilityInquiry
Batchno.20251124 1mg Out of stock Inquiry
Batchno.20250402 5mg In stock Inquiry
Batch No.PackageAvailabilityInquiry
Batchno.20250622 1mg Out of stock Inquiry
Batchno.20251126 5mg In stock Inquiry
  • Product code: ICTD3672
GET A QUOTE

54328-33-5 / (2R,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate

Standard CAS: 54328-33-5 Multi CAS: Yes

Basic Information

CAS
54328-33-5
Multi CAS
Yes
Molecular Formula
C14H21NO15S-2
Molecular Weight
475.400000
Exact Mass
475.063190
InChI
InChI=1S/C14H23NO15S/c1-3(17)15-5-10(9(30-31(24,25)26)4(2-16)27-13(5)23)28-14-8(20)6(18)7(19)11(29-14)12(21)22/h4-11,13-14,16,18-20,23H,2H2,1H3,(H,15,17)(H,21,22)(H,24,25,26)/p-2/t4-,5-,6+,7+,8-,9+,10-,11-,13-,14-/m1/s1
InChIKey
AVJBPWGFOQAPRH-FWMKGIEWSA-L

Computed Properties

Structural Parameters

Heavy atom count
31
Fraction Csp3
0.86
Rotatable bonds
7
H-bond acceptors
15
H-bond donors
6
Molar refractivity
86.7
TPSA
264.5

LogP / Solubility

WLOGP
-7.01
MLOGP
-6.14
XLogP3
-4.3
Consensus LogP
-5.82
Log S (ESOL)
2.09
Class (ESOL)
Highly soluble
Log S (Ali)
1.6
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
2.23
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-10.6

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
7.5

Get In Touch

Contact Us